MCID: PYR010
MIFTS: 53

Peyronie's Disease malady

Categories: Rare diseases, Reproductive diseases

Aliases & Classifications for Peyronie's Disease

About this section
Sources:
11Disease Ontology, 13DISEASES, 30ICD10, 32ICD9CM, 36MalaCards, 39MeSH, 45NCIt, 48NIH Rare Diseases, 50Novoseek, 62SNOMED-CT, 68UMLS
See all MalaCards sources

Aliases & Descriptions for Peyronie's Disease:

Name: Peyronie's Disease 36 11 13
Peyronie Disease 11 48 50 68
Balanitis Xerotica Obliterans 68
Induratio Penis Plastica 11
 
Peyronie's Fibromatosis 11
Penile Induration 39
Peyronies Disease 36
Penile Curvature 48

Classifications:



External Ids:

Disease Ontology11 DOID:8616
ICD1030 N48.6
ICD9CM32 607.85
MeSH39 D010411
NCIt45 C3316

Summaries for Peyronie's Disease

About this section
NIH Rare Diseases:48 Peyronie disease is a connective tissue disorder characterized by a plaque, or hard lump, that forms within the penis. Affected individuals may experience painful, curved erections which can make make normal sexual intercourse impossible. Symptoms may appear suddenly or develop gradually. While the painful erections for most men resolve over time, the scar tissue and curvature may remain. Some cases appear to resolve spontaneously. The exact cause of Peyronie's disease is not known. Last updated: 11/23/2011

MalaCards based summary: Peyronie's Disease, also known as peyronie disease, is related to dupuytren contracture dupuytren contracture 1, included and keratopathy, and has symptoms including abnormality of the genitourinary system, abnormality of the skeletal system and edema of penis. An important gene associated with Peyronie's Disease is IFNA2 (Interferon Alpha 2), and among its related pathways are NO-dependent CFTR activation (normal and CF) and Nitric oxide stimulates guanylate cyclase. Affiliated tissues include small intestine, bone and prostate, and related mouse phenotypes are renal/urinary system and respiratory system.

Wikipedia:71 Peyronie\'s disease or Peyronie disease (/peɪroʊˈniː/), also known as induratio penis plastica (IPP)... more...

Related Diseases for Peyronie's Disease

About this section

Diseases related to Peyronie's Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 33)
idRelated DiseaseScoreTop Affiliating Genes
1dupuytren contracture dupuytren contracture 1, included10.8
2keratopathy10.3SMAD3, TGFB1
3diamond-blackfan anemia10.3TGFB1, TGFB2
4acromicric dysplasia10.3TGFB1, TGFB2
5fibrosclerosis of breast10.2TGFB1, TGFB2
6hypospadias10.2
7tgfbr1-related loeys-dietz syndrome10.2TGFB2, TGFB3
8peanut allergy10.2TGFB1, TGFB2
9loeys-dietz syndrome 410.2TGFB2, TGFB3
10vitreous abscess10.2TGFB1, TGFB2
11renal clear cell carcinoma10.2TGFB2, TGFB3
12leukemia10.1TGFB1, TGFB2
13naegeli-franceschetti-jadassohn syndrome/dermatopathia pigmentosa reticularis10.1DCN, TGFB1
14strawberry gallbladder10.0TGFB1, TGFB2, TGFB3
15serous labyrinthitis10.0PDE5A, TGFB1
16idiopathic corneal edema10.0TGFB1, TGFB2, TGFB3
17brucella canis brucellosis10.0SMAD3, TGFB2
1846 xy gonadal dysgenesis10.0TGFB1, TGFB2, TGFB3
19actinomycosis10.0DCN, SMAD3, TGFB1
20adenosine monophosphate deaminase deficiency erythrocyte type10.0SMAD3, TGFB2, TGFB3
21loin pain hematuria syndrome9.9SMAD7, TGFB1
22west syndrome9.8DCN, TGFB2
23pulmonary edema9.8
24priapism9.8
25beare-stevenson cutis gyrata syndrome9.7DCN, TGFB1
26head and neck carcinoma9.7IFNA2, PDE5A, SMAD3, TGFB1
27benign neonatal seizures9.7SMAD3, SMAD7, TGFB1
28epidemic typhus9.7SMAD3, TGFB1, TGFB2, TGFB3
29benign struma ovarii9.7SMAD3, SMAD7, TGFB1
30acromesomelic dysplasia9.6SMAD3, SMAD7, TGFB3
31nephropathy familial with hyperuricemia9.3DCN, SMAD3, SMAD7, TGFB1
32colorectal cancer8.3IFNA2, NOS2, SMAD3, SMAD7, TGFB1, TGFB2
33twin-to-twin transfusion syndrome7.7ACTG2, DCN, IFNA2, SMAD3, SMAD7, TGFB1

Comorbidity relations with Peyronie's Disease via Phenotypic Disease Network (PDN):


Prostatic HypertrophyBladder Neck Obstruction
Urethral Stricture

Graphical network of the top 20 diseases related to Peyronie's Disease:



Diseases related to peyronie's disease

Symptoms & Phenotypes for Peyronie's Disease

About this section

Human phenotypes related to Peyronie's Disease:

 64
id Description HPO Frequency HPO Source Accession
1 abnormality of the genitourinary system64 HP:0000119
2 abnormality of the skeletal system64 HP:0000924

UMLS symptoms related to Peyronie's Disease:


edema of penis, discharge from penis, pain in penis, penile swelling, penile burning sensation

MGI Mouse Phenotypes related to Peyronie's Disease according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053679.1DCN, NOS2, SMAD3, TGFB1, TGFB2
2MP:00053889.0DCN, NOS2, TGFB1, TGFB2, TGFB3
3MP:00053699.0DCN, NOS2, SMAD7, TGFB1, TGFB2
4MP:00053798.6DCN, NOS2, SMAD3, SMAD7, TGFB1, TGFB2
5MP:00053908.6DCN, NOS2, SMAD3, TGFB1, TGFB2, TGFB3
6MP:00053898.6DCN, NOS2, SMAD3, SMAD7, TGFB1, TGFB2
7MP:00053848.2DCN, NOS2, SMAD3, SMAD7, TGFB1, TGFB2
8MP:00053828.1DCN, NOS2, SMAD3, SMAD7, TGFB1, TGFB2
9MP:00053818.1DCN, NOS2, SMAD3, SMAD7, TGFB1, TGFB2
10MP:00053917.8DCN, NOS2, SMAD3, TGFB1, TGFB2, TGFB3

Drugs & Therapeutics for Peyronie's Disease

About this section

Drugs for Peyronie's Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 49)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
SevelamerapprovedPhase 37452757-95-6, 152751-57-03085017
Synonyms:
Sevelamer
 
Sevelamero
Sevelamerum
Sévélamer
2Chelating AgentsPhase 31365
3
AcetylcholineapprovedPhase 277651-84-3187
Synonyms:
ACh
Acetyl choline ion
Acetylcholine Chloride
Acetylcholine cation
 
Acetylcholinium: acetyl-Choline
Choline acetate
Choline acetate (ester)
O-Acetylcholine
acetylcholine chloride
4
Lidocaineapproved, vet_approvedPhase 21226137-58-63676
Synonyms:
.alpha.-(Diethylamino)-2,6-acetoxylidide
.alpha.-Diethylamino-2,6-dimethylacetanilide
.alpha.-Diethylaminoaceto-2,6-xylidide
.omega.-Diethylamino-2,6-dimethylacetanilide
137-58-6
2-(Diethylamino)-2',6'-acetoxylidide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide
2-Diethylamino-N-(2,6-dimethylphenyl)acetamide
4-12-00-02538 (Beilstein Handbook Reference)
6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE))
6108-05-0 (mono-hydrochloride, mono-hydrate)
73-78-9 (mono-hydrochloride)
AB00053581
AC-10282
AC1L1GGQ
AC1Q2Z7J
AKOS001026768
ARONIS23855
After Burn Double Strength Gel
After Burn Double Strength Spray
After Burn Gel
After Burn Spray
Alphacaine
Anestacon
Anestacon Jelly
BIDD:GT0342
BPBio1_000197
BRD-K52662033-001-02-6
BRD-K52662033-003-05-5
BRN 2215784
BSPBio_000179
BSPBio_001359
BSPBio_003004
Bio-0767
Bio1_000379
Bio1_000868
Bio1_001357
Bio2_000079
Bio2_000559
C07073
C14H22N2O
CAS-73-78-9
CDS1_000283
CHEBI:6456
CHEMBL79
CID3676
CPD000058189
Cappicaine
Cito optadren
Cuivasil
D00358
DB00281
Dalcaine
Dentipatch
Dentipatch (TN)
DermaFlex
Diethylaminoaceto-2,6-xylidide
Dilocaine
DivK1c_000174
DivK1c_001323
Duncaine
EINECS 205-302-8
ELA-Max
EMBOLEX
Emla
Emla Cream
Esracaine
FT-0082378
Gravocain
HMS1791D21
HMS1989D21
HMS2051C21
HMS2089E15
HMS548M19
HSDB 3350
I01-2704
IDI1_000174
IDI1_033829
Isicaina
Isicaine
Jetocaine
KBio1_000174
KBio2_000079
KBio2_001598
KBio2_002647
KBio2_004166
KBio2_005215
KBio2_006734
KBio3_000157
KBio3_000158
KBio3_002224
KBioGR_000079
KBioGR_000599
KBioSS_000079
KBioSS_001598
L-Caine
L0156
L1026_SIGMA
L7757_SIGMA
LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE)
LIDOPEN
LQZ
 
LS-805
Lanabiotic
Leostesin
Lida-Mantle
Lidocaina
Lidocaina [INN-Spanish]
Lidocaine (JP15/USP/INN)
Lidocaine (VAN)
Lidocaine Carbonate
Lidocaine Hydrocarbonate
Lidocaine Monohydrochloride
Lidocaine [USAN:INN:JAN]
Lidocainum
Lidocainum [INN-Latin]
Lidocaton
Lidoderm
Lidoject-1
Lidoject-2
Lignocaine
Lignocainum
Lingocaine
Lopac-L-5647
Lopac0_000669
MLS000069724
MLS000758263
MLS001074177
Maricaine
Maybridge1_002571
MolPort-001-783-478
N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide
N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide
NCGC00015611-01
NCGC00015611-02
NCGC00015611-03
NCGC00015611-04
NCGC00015611-14
NCGC00022176-05
NCGC00022176-06
NCGC00022176-07
NCGC00022176-08
NCGC00022176-09
NINDS_000174
NSC 40030
NSC40030
Norwood Sunburn Spray
Octocaine
Octocaine-100
Octocaine-50
Prestwick0_000050
Prestwick1_000050
Prestwick2_000050
Prestwick3_000050
Remicaine
Rocephin Kit
Rucaina
S1357_Selleck
SAM001247018
SMR000058189
SPBio_001525
SPBio_002100
STK552033
Solarcaine
Solarcaine aloe extra burn relief cream
Solcain
Spectrum2_001343
Spectrum3_001392
Spectrum4_000070
Spectrum5_001549
Spectrum_001118
UNII-98PI200987
WLN: 2N2 & 1VMR B1 F1
Xilina
Xilocaina
Xilocaina [Italian]
Xllina
Xycaine
Xylestesin
Xylesthesin
Xylocain
Xylocaine
Xylocaine (TN)
Xylocaine 5% Spinal
Xylocaine CO2
Xylocaine Dental Ointment
Xylocaine Endotracheal
Xylocaine Test Dose
Xylocaine Viscous
Xylocaine-MPF
Xylocaine-MPF with Glucose
Xylocaine-Mpf
Xylocaine-Mpf with Glucose
Xylocard
Xylocitin
Xyloneural (free base)
Xylotox
Zilactin-L
Zingo
alfa-Dietilamino-2,6-dimetilacetanilide
alfa-Dietilamino-2,6-dimetilacetanilide [Italian]
alpha-Diethylamino-2,6-dimethylacetanilide
alpha-diethylamino-2,6-dimethylacetanilide
lidocaine
nchembio.65-comp16
α-diethylamino-2,6-dimethylacetanilide
5onabotulinumtoxinAPhase 2626
6Peripheral Nervous System AgentsPhase 222776
7Pharmaceutical SolutionsPhase 27793
8Neurotransmitter AgentsPhase 217734
9incobotulinumtoxinAPhase 2635
10Botulinum ToxinsPhase 2669
11abobotulinumtoxinAPhase 2626
12Neuromuscular AgentsPhase 21129
13Botulinum Toxins, Type APhase 2630
14Cholinergic AgentsPhase 23846
15Diuretics, Potassium SparingPhase 21827
16Sodium Channel BlockersPhase 21515
17Central Nervous System DepressantsPhase 212806
18Anesthetics, LocalPhase 23272
19AnestheticsPhase 29001
20Anti-Arrhythmia AgentsPhase 22969
21
MethyltestosteroneapprovedPhase 154658-18-46010
Synonyms:
17(alpha)-Methyl-delta(4)-androsten-17(beta)-ol-3-one
17-Methyltestosterone
17-beta-Hydroxy-17-methylandrost-4-en-3-one
17-methyltestosterone
17alpha-Methyl-3-oxo-4-androsten-17beta-ol
17alpha-Methyl-delta(4)-androsten-17beta-ol-3-one
17alpha-Methyltestosterone
17alpha-methyl-delta-androsten-17beta-ol-3-one
17alpha-methyltestosterone
 
17beta-Hydroxy-17-methylandrost-4-en-3-one
17α-methyl-Δ4-androsten-17β-ol-3-one
17α-methyltestosterone
4-Androstene-17alpha-methyl-17beta-ol-3-one
Android
Methyltestosterone
Methyltestosteronum
Metiltestosterona
NSC-9701
Testred
Virilon
22
Testosteroneapproved, investigationalPhase 154658-22-06013
Synonyms:
(+)-testosterone
(+-)-8-iso-testosterone
(+-)-retrotestosterone
(+-)-testosterone
(17b)-17-hydroxy-androst-4-en-3-one
(17beta)-17-Hydroxyandrost-4-en-3-one
(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
13-Iso-testosterone
17-Hydroxy-(17-beta)-androst-4-en-3-one
17-Hydroxy-(17beta)-androst-4-en-3-one
17-Hydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-one
17-Hydroxy-D4-androsten-3-one
17-Hydroxy-androst-4-en-3-one
17-beta-Hydroxy-delta(sup 4)-androsten-3-one
17-beta-Hydroxyandrost-4-en-3-one
17?-Hydroxy-4-androsten-3-one
17a-Hydroxy-(13a)-androst-4-en-3-one
17a-Hydroxy-13a-androst-4-en-3-one
17a-Hydroxy-14b-androst-4-en-3-one
17a-Hydroxy-androst-4-en-3-one
17b-Hydroxy-(10a)-androst-4-en-3-one
17b-Hydroxy-(13a)-androst-4-en-3-one
17b-Hydroxy-(8a)-androst-4-en-3-one
17b-Hydroxy-(8a,10a)-androst-4-en-3-one
17b-Hydroxy-(9b)-androst-4-en-3-one
17b-Hydroxy-(9b,10a)-androst-4-en-3-one
17b-Hydroxy-13a-androst-4-en-3-one
17b-Hydroxy-8a-androst-4-en-3-one
17b-Hydroxy-D4-androsten-3-one
17b-Hydroxy-androst-4-en-3-on
17b-Hydroxy-androst-4-en-3-one
17b-Hydroxyandrost-4-en-3-one
17b-Hydroxyandrost-4-ene-3-one
17b-Testosterone
17b-hydroxy-4-androsten-3-one
17beta-Hydroxy-3-oxo-4-androstene
17beta-Hydroxy-4-androsten-3-one
17beta-Hydroxy-delta(sup4)-androsten-3-one
17beta-Hydroxyandrost-4-en-3-one
17beta-Hydroxyandrost-4-ene-3-one
17beta-hydroxy-4-androsten-3-one
4-Androsten-17?-ol-3-one
4-Androsten-17beta-ol-3-one
4-Androsten-3-one-17b-ol
4-androsten-17β-ol-3-one
4-androstene-17beta-ol-3-one
46923_FLUKA
46923_RIEDEL
58-22-0
7-beta-Hydroxyandrost-4-en-3-one
8-Iso-testosterone
9b,10a-Testosterone
9b-Testosterone
AA 2500
AC-14899
AC1L1LM0
Andriol
Andro
Andro 100
Andro L.A. 200
AndroGel
Androderm
Androderm (TN)
Androgel
Androgel (TN)
Android 10
Android 25
Android 5
Androlin
Andronaq
Andronate 100
Andronate 200
Andropatch
Andropository 200
Androsorb
Androst-4-en-17b-ol-3-one
Androst-4-en-17beta-ol-3-one
Androst-4-ene-17b-ol-3-one
Andrusol
Andryl 200
B5DEE83F-632B-48A1-A0ED-A51E7F13DF2E
BIDD:ER0555
BIM-0061761.0001
Beta Testosterone
Bio-0678
Bio-T-Gel
C00535
CCRIS 574
CDB 111C
CHEBI:17347
CHEMBL386630
CID6013
CMC_13449
COL 1621
CP 601B
CPD000058344
Cristerona T
Cristerone T
D00075
D4-Androsten-17b-ol-3-one
DB00624
Dea No. 4000
Delatest
Delatestryl
Depo-Testadiol
Depo-Testosterone
Depo-Testosterone Cypionate
Depotest
EINECS 200-370-5
Epitestosteron
Everone 200
Geno-Cristaux Gremy
Geno-cristaux Gremy
Geno-cristaux gremy
HMS2052N11
HSDB 3398
Halotensin
Homosteron
Homosterone
 
Intrinsa
LMST02020002
LS-148813
LibiGel
Libigel
Lumitestosteron
MLS000563091
MLS001032098
MLS001306401
MLS002174283
Malerone
Malestrone
Malestrone (amps)
Malogen in Oil
Malogen, Aquaspension Injection
Malogen, aquaspension injection
Mertestate
Metandren
Methyltestosterone
MolPort-002-506-901
NCGC00091018-01
NSC 9700
Neo-Hombreol F
Neo-Testis
Neo-testis
Neotestis
Oreton
Oreton F
Oreton Methyl
Oreton-F
Orquisteron
Perandren
Percutacrine Androgenique
Percutacrine androgenique
Primotest
Primoteston
Rac-17b-hydroxy-(13a)androst-4-en-3-one
Rac-17b-hydroxy-(8a)-androst-4-en-3-one
Rac-17b-hydroxy-(9b,10a)androst-4-en-3-one
Rac-17b-hydroxy-androst-4-en-3-one
Relibra
Retrotestosterone
S00309
S2033_Selleck
SAM001246921
SMR000058344
SMR001261453
Scheinpharm Testone-Cyp
Striant
Striant (TN)
Sustanon
Sustanone
Sustason 250
Synandrol F
T-Cypionate
T1500_SIGMA
T5411_FLUKA
T5411_SIGMA
TES
Teslen
Testamone 100
Testandrone
Testaqua
Testiculosterone
Testim
Testim (TN)
Testobase
Testoderm
Testoderm Tts
Testogel
Testoject-50
Testolent
Testolin
Testopel Pellets
Testopropon
Testosteroid
Testosteron
Testosterona
Testosterona [INN-Spanish]
Testosterone
Testosterone (JAN/USP)
Testosterone Cypionate
Testosterone Enanthate
Testosterone Hydrate
Testosterone [Androgenic steroids, anabolic]
Testosterone [INN:BAN]
Testosterone and its esters
Testosterone hydrate
Testosterone solution
Testosteronum
Testosteronum [INN-Latin]
Testostosterone
Testostérone
Testoviron
Testoviron Schering
Testoviron T
Testoxyl
Testred
Testred Cypionate 200
Testrin-P.A
Testro AQ
Testro Aq
Testrone
Testryl
Tostrelle
Tostrex
Trans-Testosterone
UNII-3XMK78S47O
Viatrel
Virilon
Virilon IM
Virormone
Virosterone
ZINC06500184
beta testosterone
delta(sup 4)-Androsten-17(beta)-ol-3-one
delta4-Androsten-17beta-ol-3-one
delta4-androsten-17b-ol-3-one
testosterone
trans-Testosterone
23
Vitamin Eapproved, nutraceutical, vet_approvedPhase 140659-02-914985
Synonyms:
(+)-a-Tocopherol
(+)-alpha-Tocopherol
(+)-α-tocopherol
(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL
(2R)-3,4-Dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol
(2R,4'R,8'R)-a-Tocopherol
(2R,4'R,8'R)-alpha-Tocopherol
(2R,4'R,8'R)-α-tocopherol
(R,R,R)-a-Tocopherol
(R,R,R)-alpha-Tocopherol
(R,R,R)-α-tocopherol
5,7,8-Trimethyltocol
5,7,8-trimethyltocol
Amino-Opti-E
Aquasol E
D-alpha-Tocopherol
Daltose
Denamone
E-200 I.U. Softgels
 
E-Complex-600
E-Ferol
E-Vitamin succinate
Eprolin
Gordo-Vite E
Phytogermin
Phytogermine
RRR-alpha-tocopherol
RRR-alpha-tocopheryl
Tocopherol
Vitamin E
Vitamin Ea
Vitamin Plus E Softgells
Vitec
a-D-Tocopherol
a-Tocopherol
alpha-Tocopherol
alpha-delta-Tocopherol
alpha-tocopherol
d-α-tocopherol
delta-alpha-Tocopherol
24
Ergocalciferolapproved, nutraceuticalPhase 1123250-14-65280793
Synonyms:
'Ergosterol irradiated'
(+)-Vitamin D2
(3-beta,5Z,7E,22E)-9,10-Secoergosta-5,7,10,(19),22-tetraen-3-ol
(3S,5Z,7E,14xi,17alpha,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3beta,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
(5E,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
22-Tetraen 3beta 9,10,Secoergosta-5,7,10(19)-ol
31316-19-5
4-Methylene-3-[2-[tetrahydro-7a-methyl-1-(1,4,5-trimethyl-2-hexenyl)-4(3aH)-indanylidene]ethylidene]-Cyclohexanol
47768_SUPELCO
50-14-6
7489-18-1
7E677DC1-E1C4-4FC5-8F4A-BCE1857F7E87
8017-28-5
9,10,Secoergosta-5,7,10(19),22-tetraen 3.beta.-ol
9,10-Seco(5Z,7E,22E)-5,7,10(19),22-ergostatetraen-3-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3-beta-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3b-ol
95220_FLUKA
95220_SIGMA
AC-1355
AC1L1FIE
AC1NQXLH
AC1NS4DE
AC1NS9GI
AC1NSSVD
AC1NWAM3
AC1O5EDK
AC1O6WAM
ACon1_002187
Activated ergosterol
BPBio1_000418
BSPBio_000380
BSPBio_001974
Buco-D
C05441
C28H44O
CALCIFEROL IN A GELATIN MATRIX
CALCIFEROL, U.S.P.
CHEBI:28934
CHEMBL1536
CID11003810
CID3249
CID5280793
CID5315257
CID5353610
CID5356615
CID5702050
CID6432478
CID6536972
Calciferol
Calciferol (TN)
Calciferol (vitamin D2)
Calciferolum
Calciferon 2
Condacaps
Condocaps
Condol
Crtron
Crystallina
D-Arthin
D-Tracetten
D00187
DB00153
Daral
Davitamon D
Davitin
De-rat concentrate
Decaps
Dee-Osterol
Dee-Ron
Dee-Ronal
Dee-Roual
Deltalin
Deratol
Detalup
Diactol
Divit urto
Doral
Drisdol
Drisdol (TN)
E5750_SIGMA
EINECS 200-014-9
Ercalciol
Ergocalciferol
Ergocalciferol (D2)
Ergocalciferol (JP15/USP)
Ergocalciferol [INN:BAN:JAN]
Ergocalciferol oil
Ergocalciferol: Vitamin D
 
Ergocalciferolo
Ergocalciferolo [DCIT]
Ergocalciferols
Ergocalciferolum
Ergocalciferolum [INN-Latin]
Ergorone
Ergosterol activated
Ergosterol irradiated
Ergosterol, irradiated
Ertron
Fortodyl
Geltabs
Geltabs Vitamin D
HMS1920K20
HMS2091B19
HMS502I07
HSDB 819
Haliver
Hi-Deratol
Hyperkil
I05-0022
IDI1_000805
Infron
Irradiated ergosta-5,7,22-trien-3-beta-ol
Irradiated ergosta-5,7,22-trien-3.beta.-ol
Irradiated ergosta-5,7,22-trien-3beta-ol
Irradiated ergosterol
LMST03010001
LMST03010014
LS-3228
MEGxm0_000466
MLS001332467
MLS001332468
Metadee
Mina D2
MolPort-001-740-057
MolPort-001-793-930
MolPort-002-526-645
MolPort-003-666-178
MolPort-006-822-629
Mulsiferol
Mykostin
NCGC00142497-01
NCGC00179579-01
NCGC00179579-02
NSC 62792
NSC62792
Novovitamin-D
Oleovitamin D
Oleovitamin D, Synthetic
Oleovitamin D2
Osteil
Ostelin
Prestwick3_000420
Prestwick_554
Radiostol
Radstein
Radsterin
Rodine C
Rodinec
SMR000857106
SPECTRUM1500276
ST057150
STOCK1N-53397
Shock-ferol
Shock-ferol sterogyl
Sorex C.R
Sorex C.R.
Spectrum5_000666
Sterogyl
Synthetic Vitamin D
UNII-VS041H42XC
Uvesterol D
Uvesterol-D
VITAMIN D2
VITAMIN D2 WATER DISPERSABLE U.S.P.
VITAMIN_D2
Vigantol
Vio D
Vio-D
Viostdrol
Viosterol
Viosterol in Oil
Vitamin D2
Vitamin- D2
Vitamin-?D2
Vitamina D2
Vitavel-D
WLN: L56 FYTJ A1 BY1&1U1Y1&Y1&1 FU2U- BL6YYTJ AU1 DQ
ZINC04474571
ZINC04629876
beta-Ol
bmse000510
component of Geltabs Vitamin D
delta-Arthin
delta-Tracetten
ergocalciferol
vitamin d-2
25Testosterone 17 beta-cypionatePhase 1546
26Testosterone undecanoatePhase 1546
27
Testosterone enanthatePhase 1546315-37-79416
Synonyms:
17-((1-Oxoheptyl)oxy)androst-4-en-3-one
17-Hydroxyandrost-4-en-3-one, 17-heptanoate
17-Hydroxyandrost-4-en-3-one, 17-heptanoic acid
17beta-Enanthoxyandrost-4-en-3-one
17beta-Hydroxyandrost-4-en-3-one enanthate
4-Androsten-17beta-ol-3-one 17-enanthate
4-Androsten-3-one 17beta-enanthate
Androgyn L.A.
Andropository
Androtardyl
Atlatest
DEA No. 4000
DePatestrye
Delatest
Delatestryl
Depo-Testro Med
Ditate
Durathate
Everone
 
Exten test
Malogen L.A.
Malogen L.A.200
Orquisteron-E
Primotestone
Reposo TMD
Testanthate
Testate
Testenate
Testinon
Testoenant
Testonenant
Testosterone 17-enanthate
Testosterone 17beta-heptanoate
Testosterone 17beta-heptanoic acid
Testosterone enantate
Testosterone heptoate
Testosterone heptoic acid
Testosterone heptylate
Testosterone oenanthate
Testostroval
28TocotrienolsPhase 1402
29VitaminsPhase 15095
30vitamin dPhase 11653
31Trace ElementsPhase 15802
32Protective AgentsPhase 17190
33TocopherolsPhase 1406
34Bone Density Conservation AgentsPhase 13266
35AndrogensPhase 11275
36MicronutrientsPhase 15802
37AntioxidantsPhase 12928
38Antineoplastic Agents, HormonalPhase 15407
39ErgocalciferolsPhase 11232
40Anabolic AgentsPhase 1499
41Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 112767
42HormonesPhase 113979
43Hormone AntagonistsPhase 112778
44Vitamin D2NutraceuticalPhase 11232
45CalciferolNutraceuticalPhase 11334
46TocotrienolNutraceuticalPhase 1402
47TocopherolNutraceuticalPhase 1406
48Phosphodiesterase 5 Inhibitors571
49Mitogens1526

Interventional clinical trials:

(show all 20)
idNameStatusNCT IDPhase
1Long-term Safety, Curvature Deformity Characterization, and Immunogenicity Over Time in Subjects Previously Treated With AA4500 for Peyronies DiseaseActive, not recruitingNCT02298829Phase 4
2A Study of AA4500 in Men With Peyronie's DiseaseCompletedNCT01243411Phase 3
3A Phase 3, Open-label Study of the Safety and Effectiveness of AA4500 Administered Twice Per Treatment Cycle for up to Four Treatment Cycles (2 x 4) in Men With Peyronie's DiseaseCompletedNCT01685437Phase 3
4Study of AA4500 in the Treatment of Peyronie's DiseaseCompletedNCT01221597Phase 3
5Study of AA4500 in the Treatment of Peyronie's DiseaseCompletedNCT01221623Phase 3
6An Open-label Study to Assess the Safety and Effectiveness of AA4500 in Combination With the ErecAid® Esteem® Manual Vacuum Therapy System in Treating Men With Peyronie's DiseaseCompletedNCT02267460Phase 3
7A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Sevelamer Carbonate Tablets Dosed Three Times a Day in Hyperphosphataemic Chronic Kidney Disease Patients Not on DialysisTerminatedNCT00833768Phase 3
8Dupuytren's Disease and Extracorporeal Shockwave Therapy (DupuyShock-2010)Unknown statusNCT01184586Phase 2
9The Safety and Effectiveness of AA4500 in Subjects With Peyronie's DiseaseCompletedNCT00755222Phase 2
10Pharmacokinetics of a Single Treatment Cycle of AA4500 0.58 mg in Men With Peyronie's DiseaseCompletedNCT01430169Phase 2
11H-22411: BOTOX® for Peyronie's DiseaseRecruitingNCT00812838Phase 2
12Clostridium Histolyticum Collagenase Injection for Urethral DiseaseNot yet recruitingNCT02948842Phase 2
13Peyronie's Disease Treatment ProtocolCompletedNCT02072018Phase 1
14Evaluate the Safety and Feasibility of Injecting PMD-MSC Into the Penis to Treat the Symptoms of PDCompletedNCT02395029Phase 1
15Testosterone Pellets Plus Vitamin D and E Versus Vitamin D and E Alone for the Treatment of Peyronie's DiseaseActive, not recruitingNCT01578473Phase 1
16Efficacy of Extracorporal Shock Wave Therapy in Patient With Chronic Non-bacterial Prostatitis / Chronic Pelvic Pain SyndromeUnknown statusNCT01714830
17Change in Penile Length Following Bilateral Nerve-Sparing Radical ProstatectomyCompletedNCT00800813
18Management of Peyronie's Disease With Adipose Tissue Stem CellRecruitingNCT02414308
19Safety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary ConditionsRecruitingNCT01953523
20Pregnant Women With a Breast Cancer Diagnosed Between 2000 and 2014RecruitingNCT01503034

Search NIH Clinical Center for Peyronie's Disease


Cochrane evidence based reviews: penile induration

Genetic Tests for Peyronie's Disease

About this section

Anatomical Context for Peyronie's Disease

About this section

MalaCards organs/tissues related to Peyronie's Disease:

36
Small intestine, Bone, Prostate, Kidney, Endothelial, Testes, Monocytes

Publications for Peyronie's Disease

About this section

Articles related to Peyronie's Disease:

(show top 50)    (show all 624)
idTitleAuthorsYear
1
Moving from Consensus- to Evidence-Based Clinical Practice Guidelines for Peyronie's Disease. (28065352)
2017
2
Response and Rebuttal to Letter to the Editor: Evidence-Based Management Guidelines on Peyronie's Disease. (28065353)
2017
3
Role of extracorporeal shock wave therapy in management of Peyronie's disease: A preliminary report. (28057983)
2016
4
A prospective, randomized, single - blind study comparing intraplaque injection of thiocolchicine and verapamil in Peyronie's Disease: a pilot study. (24893912)
2016
5
Collagenase Clostridium Histolyticum for the Treatment of Peyronie's Disease: A 'Real World' Clinical Perspective. (27770352)
2016
6
Satisfaction of patients with Peyronie's disease after plaque surgery and bovine pericardium graft. (27468940)
2016
7
Intralesional Injection of Hyaluronic Acid in Patients Affected With Peyronie's Disease: Preliminary Results From a Prospective, Multicenter, Pilot Study. (26984291)
2016
8
The Outcome of Multiple Slit on Plaque with Plication Technique for the Treatment of Peyronie's Disease. (27169125)
2016
9
Con: does shockwave therapy have a place in the treatment of Peyronie's disease? (27298785)
2016
10
Nonsurgical Interventions for Peyronie's Disease: Update as of 2016. (27574590)
2016
11
Re: The Prevalence of Peyronie's Disease in the United States: AA Population-Based Study. (27628825)
2016
12
The Therapeutic Effects of Intracavernosal Plaque Excision in Peyronie's Disease: A None Grafting or Tunical Excising Procedure. (27308243)
2016
13
Alternative Splicing of IGF1 Gene as a Potential Factor in the Pathogenesis of Peyronie's Disease. (27107083)
2016
14
Grafting techniques for Peyronie's disease. (27298780)
2016
15
Research highlights on stem cell therapy for the treatment of Peyronie's disease. (27298783)
2016
16
Re: A Meta-analysis of Extracorporeal Shock Wave Therapy for Peyronie's Disease. (27567204)
2016
17
Peyronie's Disease and Injectable Collagenase Clostridium Histolyticum: Safety, Efficacy and Improvements in Subjective Symptoms. (27211926)
2016
18
Evidence-Based Management Guidelines on Peyronie's Disease. (27215686)
2016
19
The Efficacy of Medical Treatment of Peyronie's Disease: Potassium Para-Aminobenzoate Monotherapy vs. Combination Therapy with Tamoxifen, L-Carnitine, and Phosphodiesterase Type 5 Inhibitor. (27169128)
2016
20
Lengthening strategies for Peyronie's disease. (27298782)
2016
21
Re: Comparative Analysis of Tunical Plication vs. Intralesional Injection Therapy for Ventral Peyronie's Disease. (27186764)
2016
22
Results of SMSNA Survey Regarding Complications Following Intralesional Injection Therapy With Collagenase Clostridium Histolyticum for Peyronie's Disease. (27045265)
2016
23
Increased aquaporin 1 expression in the tunica albuginea of Peyronie's disease patients: an in vivo pilot study. (26972451)
2016
24
Buccal mucosa is a promising graft in Peyronie's disease surgery. Our experience and a brief literature review on autologous grafting materials. (27377087)
2016
25
Contemporary Review of Treatment Options for Peyronie's Disease. (26898900)
2016
26
The Prevalence of Peyronie's Disease in the United States: A Population-Based Study. (26907743)
2016
27
Extracorporeal shock wave therapy (ESWT) in urology: a systematic review of outcome in Peyronie's disease, erectile dysfunction and chronic pelvic pain. (27108421)
2016
28
Bicentric prospective evaluation of corporoplasty with porcine small intestinal submucosa (SIS) in patients with severe Peyronie's disease. (27864619)
2016
29
Peyronie's disease: What's around the bend? (26941488)
2016
30
A review of surgical strategies for penile prosthesis implantation in patients with Peyronie's disease. (27298781)
2016
31
Re: Outcomes of Surgical Management of Men with Peyronie's Disease with Hourglass Deformity. (27628824)
2016
32
Surgical treatment of Peyronie's disease with small intestinal submucosa graft patch. (27030055)
2016
33
A review of the epidemiology and treatment of Peyronie's disease. (27200305)
2016
34
Peyronie's Disease: Intralesional Therapy and Surgical Intervention. (27432377)
2016
35
Review of Management Options for Patients With Atypical Peyronie's Disease. (27544298)
2016
36
Re: Female Partners of Men with Peyronie's Disease Have Impaired Sexual Function, Satisfaction, and Mood, while Degree of Sexual Interference is Associated with Worse Outcomes. (27751478)
2016
37
Injectable therapy for Peyronie's disease. (27298778)
2016
38
Re: Topical Treatment for Acute Phase Peyronie's Disease Utilizing a New Gel, H-100: A Randomized, Prospective, Placebo-Controlled Pilot Study. (27186765)
2016
39
Prevalence, psychological impact, and risk factors of erectile dysfunction in patients with Peyronie's disease: a retrospective analysis of 309 cases. (27486570)
2016
40
The Genetic Basis of Peyronie's Disease: A Review. (26955480)
2016
41
Impact of Number of Cycles of Collagenase Clostridium Histolyticum on Outcomes in Patients with Peyronie's Disease. (27816605)
2016
42
Professor Wayne J.G. Hellstrom: incidence of Peyronie's disease. (26904421)
2016
43
Re: An Analysis of Case Logs from American Urologists in the Treatment of Peyronie's Disease. (27186766)
2016
44
Female Partners of Men With Peyronie's Disease Have Impaired Sexual Function, Satisfaction, and Mood, While Degree of Sexual Interference Is Associated With Worse Outcomes. (27209179)
2016
45
Re: An Analysis of Case Logs from American Urologists in the Treatment of Peyronie's Disease. (27751484)
2016
46
Nonsurgical treatment options in Peyronie's Disease: 2016 update. (27909612)
2016
47
Data vs Dogma in Peyronie's Disease. (27813380)
2016
48
--- ---Recent advances in managing Peyronie's disease. (27746896)
2016
49
Re: Outcomes of Surgical Management of Men with Peyronie's Disease with Hourglass Deformity. (27845111)
2016
50
Re: Use of a Lyophilized Bovine Pericardium Graft to Repair Tunical Defect in Patients with Peyronie's Disease: Experience in a Clinical Setting. (27628826)
2016

Variations for Peyronie's Disease

About this section

Expression for genes affiliated with Peyronie's Disease

About this section
Search GEO for disease gene expression data for Peyronie's Disease.

Pathways for genes affiliated with Peyronie's Disease

About this section

Pathways related to Peyronie's Disease according to GeneCards Suite gene sharing:

(show top 50)    (show all 51)
idSuper pathwaysScoreTop Affiliating Genes
19.7NOS2, PDE5A
2
Show member pathways
9.7NOS2, PDE5A
39.7TGFB1, TGFB3
4
Show member pathways
9.3SMAD3, SMAD7, TGFB1
59.3SMAD3, SMAD7, TGFB1
6
Show member pathways
9.3SMAD3, SMAD7, TGFB1
79.3SMAD3, SMAD7, TGFB1
8
Show member pathways
9.2SMAD7, TGFB1, TGFB3
9
Show member pathways
9.2SMAD3, TGFB1, TGFB2
10
Show member pathways
9.2SMAD3, TGFB1, TGFB2
11
Show member pathways
9.1TGFB1, TGFB2, TGFB3
129.1TGFB1, TGFB2, TGFB3
139.1TGFB1, TGFB2, TGFB3
14
Show member pathways
9.1TGFB1, TGFB2, TGFB3
15
Show member pathways
9.1TGFB1, TGFB2, TGFB3
16
Show member pathways
9.1TGFB1, TGFB2, TGFB3
179.1TGFB1, TGFB2, TGFB3
189.1TGFB1, TGFB2, TGFB3
199.1TGFB1, TGFB2, TGFB3
209.0DCN, TGFB1, TGFB2
218.8SMAD3, SMAD7, TGFB1, TGFB3
22
Show member pathways
8.7NOS2, TGFB1, TGFB2, TGFB3
238.7NOS2, TGFB1, TGFB2, TGFB3
248.7NOS2, TGFB1, TGFB2, TGFB3
25
Show member pathways
8.7SMAD3, TGFB1, TGFB2, TGFB3
26
Show member pathways
8.7SMAD3, TGFB1, TGFB2, TGFB3
278.7SMAD3, TGFB1, TGFB2, TGFB3
28
Show member pathways
8.7SMAD3, TGFB1, TGFB2, TGFB3
298.7SMAD3, TGFB1, TGFB2, TGFB3
308.7SMAD3, TGFB1, TGFB2, TGFB3
31
Show member pathways
8.7SMAD3, TGFB1, TGFB2, TGFB3
32
Show member pathways
8.7SMAD3, TGFB1, TGFB2, TGFB3
33
Show member pathways
8.7SMAD3, TGFB1, TGFB2, TGFB3
348.7SMAD3, TGFB1, TGFB2, TGFB3
35
Show member pathways
8.6DCN, TGFB1, TGFB2, TGFB3
368.6DCN, TGFB1, TGFB2, TGFB3
378.6DCN, TGFB1, TGFB2, TGFB3
388.4IFNA2, NOS2, TGFB1, TGFB2, TGFB3
39
Show member pathways
8.4IFNA2, SMAD3, TGFB1, TGFB2, TGFB3
408.4NOS2, SMAD3, TGFB1, TGFB2, TGFB3
418.4NOS2, SMAD3, TGFB1, TGFB2, TGFB3
42
Show member pathways
8.3ACTG2, TGFB1, TGFB2, TGFB3
438.2SMAD3, SMAD7, TGFB1, TGFB2, TGFB3
448.2SMAD3, SMAD7, TGFB1, TGFB2, TGFB3
45
Show member pathways
8.2SMAD3, SMAD7, TGFB1, TGFB2, TGFB3
468.2SMAD3, SMAD7, TGFB1, TGFB2, TGFB3
47
Show member pathways
8.1IFNA2, NOS2, SMAD3, TGFB1, TGFB2, TGFB3
48
Show member pathways
8.1IFNA2, NOS2, SMAD3, TGFB1, TGFB2, TGFB3
49
Show member pathways
7.9ACTG2, NOS2, TGFB1, TGFB2, TGFB3
507.9ACTG2, SMAD3, TGFB1, TGFB2, TGFB3

GO Terms for genes affiliated with Peyronie's Disease

About this section

Cellular components related to Peyronie's Disease according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1extracellular matrixGO:00310129.3DCN, TGFB1, TGFB2, TGFB3
2platelet alpha granule lumenGO:00310939.1TGFB1, TGFB2, TGFB3
3extracellular spaceGO:00056157.9ACTG2, DCN, IFNA2, TGFB1, TGFB2, TGFB3

Biological processes related to Peyronie's Disease according to GeneCards Suite gene sharing:

(show top 50)    (show all 58)
idNameGO IDScoreTop Affiliating Genes
1endoderm developmentGO:000749210.6SMAD3, TGFB1
2evasion or tolerance of host defenses by virusGO:001904910.6SMAD3, TGFB1
3lens fiber cell differentiationGO:007030610.6SMAD3, TGFB1
4negative regulation of fat cell differentiationGO:004559910.6SMAD3, TGFB1
5negative regulation of mitotic cell cycleGO:004593010.6SMAD3, TGFB1
6positive regulation of extracellular matrix assemblyGO:190120310.5SMAD3, TGFB1
7negative regulation of protein catabolic processGO:004217710.5NOS2, SMAD3
8negative regulation of T cell proliferationGO:004213010.5PDE5A, TGFB1
9frontal suture morphogenesisGO:006036410.5TGFB1, TGFB3
10mammary gland developmentGO:003087910.5TGFB1, TGFB3
11negative regulation of DNA replicationGO:000815610.5TGFB1, TGFB3
12ossification involved in bone remodelingGO:004393210.5TGFB1, TGFB3
13regulation of bindingGO:005109810.5SMAD3, TGFB1
14positive regulation of collagen biosynthetic processGO:003296710.5TGFB1, TGFB3
15positive regulation of SMAD protein import into nucleusGO:006039110.5TGFB1, TGFB3
16regulation of striated muscle tissue developmentGO:001620210.4SMAD3, TGFB1
17SMAD protein complex assemblyGO:000718310.4SMAD3, TGFB1
18regulation of epithelial to mesenchymal transition involved in endocardial cushion formationGO:190500510.4TGFB1, TGFB3
19epithelial to mesenchymal transitionGO:000183710.3TGFB1, TGFB2
20negative regulation of immune responseGO:005077710.3TGFB1, TGFB2
21positive regulation of protein localization to nucleusGO:190018210.3TGFB1, TGFB2
22odontogenesisGO:004247610.2TGFB2, TGFB3
23regulation of transforming growth factor beta2 productionGO:003290910.1SMAD3, TGFB2
24positive regulation of bone mineralizationGO:003050110.1SMAD3, TGFB1, TGFB3
25regulation of cell proliferationGO:004212710.0NOS2, TGFB1, TGFB3
26agingGO:000756810.0DCN, TGFB1, TGFB3
27cell cycle arrestGO:00070509.9SMAD3, TGFB1, TGFB2
28extrinsic apoptotic signaling pathwayGO:00971919.9SMAD3, TGFB1, TGFB2
29uterine wall breakdownGO:00427049.9TGFB2, TGFB3
30negative regulation of cell growthGO:00303089.9SMAD3, TGFB1, TGFB2
31regulation of transforming growth factor beta receptor signaling pathwayGO:00170159.9SMAD3, SMAD7, TGFB1
32cell growthGO:00160499.9TGFB1, TGFB2, TGFB3
33face morphogenesisGO:00603259.9TGFB1, TGFB2, TGFB3
34negative regulation of macrophage cytokine productionGO:00109369.8TGFB1, TGFB2, TGFB3
35ventricular septum morphogenesisGO:00604129.8SMAD7, TGFB2
36platelet degranulationGO:00025769.8TGFB1, TGFB2, TGFB3
37positive regulation of cell divisionGO:00517819.8TGFB1, TGFB2, TGFB3
38positive regulation of pathway-restricted SMAD protein phosphorylationGO:00108629.8TGFB1, TGFB2, TGFB3
39positive regulation of protein secretionGO:00507149.8TGFB1, TGFB2, TGFB3
40response to laminar fluid shear stressGO:00346169.8SMAD7, TGFB1, TGFB3
41ureteric bud developmentGO:00016579.8SMAD3, SMAD7, TGFB1
42pathway-restricted SMAD protein phosphorylationGO:00603899.8SMAD7, TGFB1, TGFB2
43regulation of apoptotic processGO:00429819.8TGFB1, TGFB2, TGFB3
44positive regulation of transcription, DNA-templatedGO:00458939.7IFNA2, SMAD3, TGFB1, TGFB3
45response to progesteroneGO:00325709.7TGFB1, TGFB2, TGFB3
46salivary gland morphogenesisGO:00074359.7TGFB1, TGFB2, TGFB3
47SMAD protein import into nucleusGO:00071849.7TGFB1, TGFB2, TGFB3
48negative regulation of gene expressionGO:00106299.7IFNA2, NOS2, TGFB1, TGFB2
49negative regulation of transforming growth factor beta receptor signaling pathwayGO:00305129.6SMAD3, SMAD7, TGFB1, TGFB3
50cell-cell junction organizationGO:00452169.5SMAD3, TGFB1, TGFB2, TGFB3

Molecular functions related to Peyronie's Disease according to GeneCards Suite gene sharing:

(show all 8)
idNameGO IDScoreTop Affiliating Genes
1collagen bindingGO:00055189.8DCN, SMAD3, SMAD7
2growth factor activityGO:00080839.7TGFB1, TGFB2, TGFB3
3transforming growth factor beta receptor bindingGO:00051609.5SMAD3, TGFB1, TGFB2
4cytokine activityGO:00051259.5IFNA2, TGFB1, TGFB2, TGFB3
5type I transforming growth factor beta receptor bindingGO:00347139.4SMAD7, TGFB1, TGFB3
6protein heterodimerization activityGO:00469829.2SMAD3, TGFB1, TGFB2, TGFB3
7type II transforming growth factor beta receptor bindingGO:00051149.1TGFB1, TGFB2, TGFB3
8type III transforming growth factor beta receptor bindingGO:00347149.1TGFB1, TGFB2, TGFB3

Sources for Peyronie's Disease

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet